Company intelligence / Profile preview

AOK Plus

Dresden, Saxony, Germany

Ownership: Private
Employees: ~6800
Development stage: Other

Overview

AOK Plus is a major German statutory health insurance (sickness fund), covering over 3 million insured individuals in the states of Saxony and Thuringia, Germany. It is not a drug or biotech development company, but serves as a payer and a real-world data provider for healthcare outcomes research, including major collaborations providing linked health claims and clinical data for studies in multiple sclerosis and other indications.[3]

Industry: Non-Academic Healthcare

Partnerships

Institut für Pharmakoökonomie und Arzneimittellogistik e.V. (IPAM)Zentrum für Klinische Neurowissenschaften, Dresden (ZKN)Cytel

Beyond the preview

Go deeper on AOK Plus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AOK Plus.

Explore the full profile